Federica Mazzuca

Pubblicazioni

Titolo Pubblicato in Anno
Diagnostic and Therapeutic Management of Primary Orbital Neuroendocrine Tumors (NETs): Systematic Literature Review and Clinical Case Presentation BIOMEDICINES 2024
Is CT Radiomics Superior to Morphological Evaluation for pN0 Characterization? A Pilot Study in Colon Cancer CANCERS 2024
The management of oligometastatic disease in colorectal cancer: present strategies and future perspectives CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2023
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study CURRENT ONCOLOGY 2023
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets FRONTIERS IN ONCOLOGY 2023
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis CANCERS 2023
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study CANCER MANAGEMENT AND RESEARCH 2022
Tumor regression grade (TRG) for gastric cancer and radiological methods on predicting response to perioperative chemotherapy. a narrative review DIGESTIVE MEDICINE RESEARCH 2022
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach RADIOLOGY AND ONCOLOGY 2022
Comparative Analysis of Regorafenib and Trifluridine/Tipiracil in Later-Line Refractory Metastatic Colorectal Cancer: A Real-Life Multicenter Retrospective Study TUMORI 2022
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis CANCER MANAGEMENT AND RESEARCH 2022
Drug–drug interactions and pharmacogenomic evaluation in colorectal cancer patients: The new drug-pin® system comprehensive approach PHARMACEUTICALS 2021
CT based radiomic approach on first line pembrolizumab in lung cancer SCIENTIFIC REPORTS 2021
Hepatocellular carcinoma drug-eluting bead transarterial chemoembolization (Deb-tace): outcome analysis using a model based on pre-treatment ct texture features DIAGNOSTICS 2021
The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon? FRONTIERS IN IMMUNOLOGY 2021
How technology can help in oncologic patient management during COVID-19 outbreak EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference INTERNATIONAL JOURNAL OF COLORECTAL DISEASE 2020
The 5-Ws of immunotherapy in head and neck cancer CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2020
[18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2020
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial CANCERS 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma